Please login to the form below

Not currently logged in
Email:
Password:

post-operative pain

This page shows the latest post-operative pain news and features for those working in and with pharma, biotech and healthcare.

FDA awards another non-opioid pain drug breakthrough status

FDA awards another non-opioid pain drug breakthrough status

post-operative period. ... The announcement follows a BTD in June for Heron Therapeutics and its HTX-011, also for post-operative pain management.

Latest news

More from news
Approximately 1 fully matching, plus 19 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    The acquisition provides Innocoll with the financial resources to continue the development of its bupivacaine collagen implant for treatment of post-operative pain. ... Innocoll (US/IE). Gurnet Point (US). Company acquisition. Company with US

  • Grünenthal's relentless pursuit of relief Grünenthal's relentless pursuit of relief

    The need is clear. Seven of the top 50 searches on Patient.info are for pain. ... and pharma product, to treat post-operative pain, and an in-licensed innovative medical sealant for wound closure.

  • Pharma deals in September 2015 Pharma deals in September 2015

    Oncology deals continue to be prominent, but the month also saw CNS-focused deals in vogue; with chronic, post-operative and neuropathic pain centre-stage. ... It is licensed to Grunenthal in Europe. The drug is being evaluated for the treatment of

  • Pharma deals during December 2012 Pharma deals during December 2012

    Exparel was launched for post-surgical pain in the US in April 2012. ... It paid $185m to acquire Incline Therapeutics, which is developing an iontophoretic transdermal fentanyl device for treatment of post-operative pain.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics